is part of the Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

How did the Indian Pharma Market Achieve Self-Sufficiency?

TAGS: Asia India
How did the Indian Pharma Market Achieve Self-Sufficiency?
A look at how India has achieved pharmaceutical self-sufficiency over the years - taking steps to become a global leader not only in the production of low-cost generic medicines but increasingly, end-to-end drug discovery and development.

The Indian pharmaceuticals market has characteristics that make it unique. First, branded generics dominate, making up for 70 to 80 per cent of the retail market, despite the fact that this country is the single largest provider of generic drugs globally.

India is supplying over 50% of global demand for various vaccines, 40% of generic demand in the United States, 25% of all medicine in United Kingdom and extremely low-cost medicine to African nations. Second, local players have enjoyed a dominant position driven by formulation development capabilities and early investments. Third, price levels are low, driven by intense competition. While India ranks tenth globally in terms of value, it is ranked third in volumes.   

These characteristics present their own opportunities and challenges, download our free report by Infomineo for in-depth anaylsis on the evolution of India's Pharma market.